The program will examine the full Spectrum of Immunosuppression and Tolerance. Featuring: * Extended abstract sessions featuring cutting-edge research focusing on immunosuppression and tolerance * Small breakout sessions designed for meaningful discussions and interaction * A more intimate and focused learning experience without concurrent plenary sessions * Joint breakfast symposia with AST collaborators: ASHI, ASN, ASTS, CTS, ILTS, ISHLT, JDRF and TTS * Educational and networking opportunities in the ASE Learning Pavilion At the conclusion of the meeting attendees will be able to discuss and understand: * The best immunosuppressive strategy for producing an optimal outcome * The pros and cons of the proliferation of minimization immunosuppression trials * What updates are needed to clinical tolerance protocols * What the extensive research on biomarkers tells us about predicting outcomes based on immunosuppressive strategies * The latest in basic research and preclinical animal models

Share